Patient and Caregiver Information | Gilotrif® (afatinib) tablets

Time 2020-10-07 10:03:31

Web Name: Patient and Caregiver Information | Gilotrif® (afatinib) tablets

WebSite: http://www.gilotrif.com

ID:73374

Keywords:

Caregiver,and,Patient,gilotrif,boehringer-ingelheim,boehringer-ingleheim,böhring

Description:

GILOTRIF is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that: has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you. has spread to other parts of the body (metastatic), and has not been previously treated for metastatic lung cancer It is not known if GILOTRIF is safe and effective in treating people with lung cancer that has resistant abnormal EGFR genes. or is used to treat people with squamous cell lung cancer that: has spread to other parts of the body, and has been previously treated with chemotherapy that contains platinum. If you have been prescribed GILOTRIF, you are not alone Discover resources and guidance to help you understand your treatment with GILOTRIF If you have non–small cell lung cancer (NSCLC) with non–resistant epidermal growth factor receptor (EGFR) mutations (metastatic), or if you have squamous cell lung cancer previously treated with platinum therapy that has started to spread, GILOTRIF may be part of your treatment plan. *Not an actual patient. Learn more about GILOTRIF Read a guide about taking GILOTRIF. My Guide walks through how GILOTRIF works and what you can expect from taking it. Download my guide If eligible, pay $0 per month The Co-pay Assistance Program ensures eligible patients pay no more than $0 per month* for GILOTRIF (conditions apply). Learn more by calling 1-877-546-5349. Track your treatment Use our downloadable diary to keep track of your treatment. It can help you remember when to take GILOTRIF and talk with your doctor about how you are feeling. Download my Diary *The Co-pay Assistance Program ensures maximum out-of-pocket cost is no more than $0 per month (subject to a maximum monthly benefit of $5,500 and a maximum annual program benefit of $25,000) for commercially insured US-resident patients. Important safety information Before you take GILOTRIF, tell your doctor if you: have a history of an ulcer, a tear (perforation) in your stomach or intestine, or diverticular disease (inflammation) in parts of your large intestine have a history of severe dry eye or any other eye problems. Tell your doctor if you wear contact lenses. Females who are able to become pregnant should use effective birth control during treatment with GILOTRIF and for at least 2 weeks after your last dose of GILOTRIF. Talk to your doctor about birth control methods that may be right for you. Tell your doctor right away if you become pregnant or think you are pregnant during treatment with GILOTRIF. are breastfeeding or plan to breastfeed. It is not known if GILOTRIF passes into your breast milk. Do not breastfeed while taking GILOTRIF and for 2 weeks after your last dose of GILOTRIF. Talk to your doctor about the best way to feed your baby if you take GILOTRIF. Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. GILOTRIF may affect the way other medicines work, and other medicines may affect the way GILOTRIF works. Taking certain medicines with GILOTRIF may increase your risk of developing a tear (perforation) in your stomach or intestine. What to avoid while taking GILOTRIF Limit your time in the sun. GILOTRIF can make your skin sensitive to sunlight. You could get or have worsening rash or acne. You could get a severe sunburn. Use sunscreen and wear a hat and clothes that cover your skin if you have to be in sunlight during treatment with GILOTRIF. GILOTRIF may cause serious side effects, including: Diarrhea. Diarrhea is common with GILOTRIF and may sometimes be severe. Severe diarrhea can cause loss of body fluid (dehydration) and kidney problems that can sometimes lead to death. During your treatment with GILOTRIF, your doctor should prescribe medicines to treat diarrhea. Take this medicine exactly as your doctor tells you to. Tell your doctor if you have diarrhea. Get medical attention right away if your diarrhea does not go away or becomes severe. Skin reactions. GILOTRIF can cause redness, rash, and acne. It is important to get treatment for skin reactions as soon as you notice them. Take medicines to help skin reactions exactly as your doctor tells you to. Get medical attention right away if you develop severe skin reactions such as peeling or blistering of the skin, or blisters in your mouth. Lung or breathing problems. GILOTRIF may cause inflammation of the lung that may lead to death. Symptoms may be similar to those symptoms from lung cancer. Tell your doctor right away if you have any new or worsening lung problems, or any combination of the following symptoms: trouble breathing or shortness of breath, cough, or fever. Liver problems. GILOTRIF can cause liver problems that can sometimes lead to death. Tell your doctor right away if you have any symptoms of a liver problem which may include: yellowing of your skin or the white part of your eyes (jaundice) dark or brown (tea-colored) urine pain on the upper right side of your stomach area (abdomen) bleeding or bruising more easily than normal feeling very tired Your doctor will do blood tests to check your liver function during your treatment with GILOTRIF. Tear (perforation) in your stomach or intestine. Tears in your stomach or intestine can happen with GILOTRIF and can sometimes lead to death. Your risk of developing a tear in your stomach or intestine may be increased if you: take certain medicines with GILOTRIF including: corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDS), and certain other medicines. have a history of stomach or intestinal ulcers, or if you have had diverticular disease (inflammation in parts of the large intestine) Get medical help right away if you develop severe stomach-area (abdomen) pain during treatment with GILOTRIF. Eye problems. Tell your doctor right away if you have symptoms of eye problems. Symptoms may include: eye pain, swelling, redness, or tearing blurred vision sensitivity to light other changes in your vision Heart problems. Tell your doctor right away if you have any symptoms of a heart problem which may include: new or worsening shortness of breath while at rest or with activity cough tiredness swelling of your ankles, feet, or legs feeling that your heart is pounding or racing (palpitations) sudden weight gain Your doctor may change your dose, temporarily stop or permanently stop treatment with GILOTRIF if you have certain side effects. The most common side effects of GILOTRIF include diarrhea, rash, acne, mouth sores, nail inflammation, dry skin, decreased appetite, nausea, vomiting, and itching. GILOTRIF may cause decreased fertility in females and males. This may affect your ability to have a child. Talk to your doctor if this is a concern for you. Tell your doctor if you have any side effect that bothers you or that does not go away. These are not all of the possible side effects of GILOTRIF. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. What is GILOTRIF? GILOTRIF is a prescription medicine that is used to treat people with non-small cell lung cancer (NSCLC) that: has certain (non-resistant) abnormal epidermal growth factor receptor (EGFR) gene(s). Your healthcare provider will perform a test to make sure that GILOTRIF is right for you. It is not known if GILOTRIF is safe and effective in treating people with lung cancer that has resistant abnormal EGFR genes. is used to treat people with squamous cell lung cancer that:

TAGS:Caregiver and Patient gilotrif boehringer-ingelheim boehringer-ingleheim böhring

<<< Thank you for your visit >>>

If you've been diagnosed with advanced Non-Small Cell Lung Cancer (NSCLC) with common EGFR mutations (Del19 or L858R), take the time to learn more about your condition and treatment options. GILOTRIF is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC), that has certain types of abnormal epidermal growth factor receptor (EGFR) genes, and who have not had previous treatment for cancer that has spread to other parts of the body It is not known if GILOTRIF is safe and effective in children. Side effects may occur. Please see important safety information and prescribing information in this website.

Hot Websites